To the Editor: Worldwide, pre-eclampsia is
a leading cause of maternal death, affecting 3% to 5% of all pregnancies.1 Recently, elevated plasma concentrations of the
endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA)
have been linked to pre-eclampsia and impaired endothelial function.2- 5